Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-Term Follow-Up Study of Adjunctive Brivaracetam in Chinese Patients With Uncontrolled Focal Epilepsy
NCT07563634Phase 3Completed
- Sponsor
- Jiangxi Qingfeng Pharmaceutical Co. Ltd.
- Start
- Feb 2021
- Primary completion
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of brivaracetam in focal epilepsy, sponsored by Jiangxi Qingfeng Pharmaceutical Co. Ltd.. Started Feb 2021; status: completed.
02
Drugs
brivaracetam
03
Conditions
focal epilepsy
Beyond the preview
Go deeper on NCT07563634.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07563634.